Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Pozuelo de Alarcón
Clinical trial register · Spain

Clinical Trials in Pozuelo de Alarcón, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC20 Hoffmann-La Roche16 Janssen Research & Development, LLC12 AstraZeneca9 Eli Lilly and Company8
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Pozuelo de Alarcón

148 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Daiichi Sankyo
Phase 1/2
220
Badalona, Barcelona, Granada, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Santa Cruz de Tenerife
2026-09-17
Recruiting
Eli Lilly and Company
Phase 3
2,001
Alcobendas, Barcelona, Centelles, Ferrol, Granada, Madrid, Pozuelo de Alarcón, Seville
2026-08-26
Recruiting
ViiV Healthcare
Phase 3
564
Pozuelo de Alarcón, Alicante, Badalona, Barcelona, Burgos, Cartagena Murcia, Córdoba, Elche Alicante
2026-06-25
Recruiting
Novartis Pharmaceuticals
Phase 1
24
Pozuelo de Alarcón, Barcelona, Madrid
2026-06-12
Recruiting
Pfizer
Phase 3
954
Madrid, A Coruña, Pozuelo de Alarcón, Seville
2026-06-10
Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
NCT07629960Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma
Blueprint Medicines Corporation
Phase 1/2
265
Barcelona, Madrid, Pozuelo de Alarcón, Pamplona
2026-06-04
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
NCT07498426Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals
Phase 3
300
Pozuelo de Alarcón, Barcelona, Las Palmas GC, Madrid, Seville
2026-06-03
Recruiting
Novartis Pharmaceuticals
Phase 1
24
Pozuelo de Alarcón, Barcelona, Madrid
2026-05-19
Recruiting
Novo Nordisk A/S
Phase 3
300
Guadalajara, Pozuelo de Alarcón, Barcelona, Castilleja de la Cuesta, Lleida, Logroño, Madrid, Vitoria-Gasteiz
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Guadalajara, Pozuelo de Alarcón, Barcelona, Castilleja de la Cuesta, Lleida, Logroño, Madrid, Vitoria-Gasteiz
2026-05-05
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
140
Hospitalet, Pozuelo de Alarcón, Barcelona, Seville
2026-04-30
Active, closed
Novo Nordisk A/S
Phase 3
606
Almería, Barcelona, León, Madrid, Málaga, Pozuelo de Alarcón, Seville
2026-04-21
Recruiting
Genmab
Phase 1
121
Logroño, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid
2026-04-07
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Badalona, A Coruña, Ferrol, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Seville
2026-03-23
Recruiting
AstraZeneca
Phase 1/2
180
Barcelona, Logroño, Pozuelo de Alarcón, Seville
2026-03-17
Recruiting
Hoffmann-La Roche
Phase 2
360
L'Hospitalet de Llobregat, Salt, Santiago de Compostela, Lleida, Pozuelo de Alarcón, El Palmar, Vigo, Barakaldo
2026-03-10
Recruiting
Incyte Corporation
Phase 3
700
Badalona, Barcelona, Las Palmas de Gran Canaria, Madrid, Majadahonda, Palma de Mallorca, Pamplona, Pozuelo de Alarcón
2026-03-05
Recruiting
Eli Lilly and Company
Phase 3
900
A Coruña, Almería, Barcelona, Ferrol, Palma de Mallorca, Pozuelo de Alarcón, Santander, Seville
2026-02-10
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Badalona, Barcelona, Granada, Madrid, Pozuelo de Alarcón, Salamanca, Usansolo, Valencia
2026-02-04
Active, closed
Longitudinal Ultrasound Assessment of Diaphragmatic and Respiratory Muscle Function Following Respiratory Muscle Training in Frail Older Adults
NCT07258615Frailty Syndrome, Respiratory Muscle Weakness, Age-Related Frailty, Geriatric Health
Universidad Francisco de Vitoria
Not applicable
30
Pozuelo de Alarcón
2026-01-12
Recruiting
Stemline Therapeutics, Inc.
Phase 1
100
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón
2026-01-10
Active, closed
Amgen
Phase 3
250
Barcelona, A Coruña, Pozuelo de Alarcón, Madrid
2025-12-19
Recruiting
Universidad Francisco de Vitoria
Not applicable
110
Pozuelo de Alarcón
2025-12-15
Recruiting
Universidad Francisco de Vitoria
Not applicable
50
Pozuelo de Alarcón
2025-12-10
Active, closed
Amgen
Phase 3
250
Barcelona, A Coruña, Pozuelo de Alarcón, Madrid
2025-11-25
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón, Valencia
2025-11-24
Recruiting
Hoffmann-La Roche
Phase 3
900
Elche, Sant Cugat del Vallès, Donostia / San Sebastian, A Coruña, Alcorcón, Pozuelo de Alarcón, Barcelona, Madrid
2025-11-24
Recruiting
BioNTech SE
Phase 1/2
245
Barcelona, Logroño, Madrid, Pozuelo de Alarcón
2025-11-18
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Barcelona, L'Hospitalet de Llobregat, Jerez de la Frontera, Albacete, Logroño, Pozuelo de Alarcón, Torrejón de Ardoz, El Palmar
2025-11-11
Recruiting
Sanofi
Phase 4
218
Santander, Barcelona, Pozuelo de Alarcón, Oviedo, Madrid
2025-09-22
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Sant Cugat del Vallès, Terrassa, Donostia / San Sebastian, Lleida, Pozuelo de Alarcón, Barcelona, Córdoba, Madrid
2025-09-17
Recruiting
Pfizer
Phase 3
6,000
Santiago de Compostela, Esplugues de Llobregat, Pozuelo de Alarcón, Torrejón de Ardoz, Madrid, Antequera, Aravaca, Seville
2025-08-25
Recruiting
BioNTech SE
Phase 1/2
1,438
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Valencia
2025-08-12
Active, closed
Windward Bio
Phase 2
136
Chiclana de la Frontera, Madrid, San Sebastián, Pozuelo de Alarcón, Benalmádena, Málaga, Seville
2025-07-24
Recruiting
Bristol-Myers Squibb
Phase 3
586
Barcelona, Donostia / San Sebastian, Santander, Pozuelo de Alarcón, Valencia, Madrid
2025-07-21
Active, closed
ViiV Healthcare
Phase 1
107
Pozuelo de Alarcón, Barcelona, Córdoba, La Laguna Santa Cruz, Madrid, Palma de Mallorca, Seville, Valencia
2025-07-10
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Denia, Martorell, Terrassa, Pozuelo de Alarcón, Barcelona, Córdoba, Donosti-San Sebastián, Granada
2025-07-02
Active, closed
Upstream Bio Inc.
Phase 2
666
Palma de Mallorca, Torrelavega, Jerez de la Frontera, Cáceres, Granada, Madrid, Pozuelo de Alarcón, Benalmádena
2025-07-02
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
L'Hospitalet de Llobregat, Bilbao, Salamanca, Jaén, Santiago de Compostela, Pozuelo de Alarcón, Valencia, Barcelona
2025-06-30
Recruiting
AstraZeneca
Phase 2
987
Benalmádena, Granollers, Madrid, Málaga, Mérida, Pozuelo de Alarcón, Santander
2025-06-27
Recruiting
GlaxoSmithKline
Phase 3
981
Pozuelo de Alarcón, Marbella, Alzira, Barcelona, Benalmádena, Ferrol, GaldakaoVizcaya, Madrid
2025-06-20
Recruiting
Janssen Research & Development, LLC
Phase 3
600
A Coruña, Barcelona, Cáceres, Jerez de la Frontera, L'Hospitalet de Llobregat, Madrid, Pamplona, Pozuelo de Alarcón
2025-06-04
Recruiting
Pfizer
Phase 2
252
Santander, Madrid, Pozuelo de Alarcón, Málaga
2025-05-20
Recruiting
BioNTech SE
Phase 1/2
380
Barcelona, Madrid, Pozuelo de Alarcón
2025-04-23
Recruiting
Bayer
Phase 1/2
450
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Málaga, Valencia, Pamplona
2025-03-21
Active, closed
Amgen
Phase 3
3,853
Almería, Castilleja de la Cuesta, Huelva, Sanlúcar de Barrameda, Seville, A Coruña, Pozuelo de Alarcón, Pamplona
2025-03-12
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Córdoba, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón, Seville, Valencia
2025-01-29
Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
NCT06747585Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma
Alentis Therapeutics AG
Phase 1/2
170
PAU de Sanchinarro, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Seville, Valencia
2024-12-16
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Barcelona, Madrid, Pozuelo de Alarcón
2024-11-27
Active, closed
Genmab
Phase 3
191
L'Hospitalet de Llobregat, Córdoba, Santiago de Compostela, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Marbella, Pamplona, Alicante
2024-11-25
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
NCT06625775Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors
DrugsBBO-10203·Ribociclib·Folfox·Fulvestrant
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1
392
Barcelona, Madrid, Pozuelo de Alarcón, Lleida, Valencia
2024-10-29
Active, closed
Eli Lilly and Company
Phase 3
1,400
Barcelona, Pozuelo de Alarcón, San Sebastián, Seville
2024-10-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Canarias, A Coruña, Pozuelo de Alarcón, Barcelona, Madrid, Málaga
2024-10-21
Recruiting
argenx
Phase 3
69
A Coruña, L'Hospitalet de Llobregat, Madrid, Murcia, Pozuelo de Alarcón, Valencia
2024-10-18
Recruiting
Janssen Research & Development, LLC
Phase 2
210
Badalona, Barcelona, El Palmar, Jerez de la Frontera, Madrid, Pozuelo de Alarcón, Salamanca
2024-08-26
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 1
60
Barcelona, Madrid, Pozuelo de Alarcón
2024-08-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Málaga, Centelles, Barcelona, Figueres, A Coruña, Santiago de Compostela, Pozuelo de Alarcón, Alcorcón
2024-08-05
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Barcelona, Getxo, Lleida, Madrid, Pamplona, Pozuelo de Alarcón, Sant Cugat del Vallès, Terrassa
2024-07-22
Active, closed
Celldex Therapeutics
Phase 3
976
Barcelona, Cadiz, Madrid, Pamplona, Pozuelo de Alarcón, Seville, Torrejón de Ardoz, Valencia
2024-07-19
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2024-06-07
Active, closed
Hoffmann-La Roche
Phase 2
256
Sant Cugat del Vallès, Donostia / San Sebastian, Pozuelo de Alarcón, Salamaca, Barcelona, Córdoba, Madrid, Seville
2024-05-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Pozuelo de Alarcón, Madrid, Valencia, Barcelona, Córdoba, Seville
2024-04-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
L'Hospitalet de Llobregat, Santiago de Compostela, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Barcelona, Madrid
2024-04-03
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Badalona, Pozuelo de Alarcón, Madrid, Barcelona, Seville
2024-03-28
Active, closed
Regeneron Pharmaceuticals
Phase 2
40
Santiago de Compostela, Granada, Palma Mallorca, Badalona, Santander, Pozuelo de Alarcón, El Palmar, Pamplona
2024-01-30
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 1
339
Barcelona, Madrid, Seville, Valencia, Málaga, Pozuelo de Alarcón
2024-01-23
Active, closed
DualityBio Inc.
Phase 3
541
Barcelona, Sant Cugat del Vallès, Santiago de Compostela, Madrid, Majadahonda, Pozuelo de Alarcón, Málaga, Pamplona
2024-01-18
Recruiting
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Phase 2
75
Pozuelo de Alarcón, A Coruña, Madrid, Málaga, Seville, Valencia
2024-01-11
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Santiago de Compostela, Palma, L'Hospitalet de Llobregat, Santander, Pozuelo de Alarcón, Oviedo, Barcelona, Granada
2023-12-28
Active, closed
AbbVie
Phase 3
614
Badalona, Getafe, Pozuelo de Alarcón, Granada, Madrid, Valencia, Zaragoza
2023-12-19
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
149
Badalona, Pozuelo de Alarcón, Pamplona, Oviedo, Alicante, Barcelona, Madrid, Salamanca
2023-12-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Sabadell, Barcelona, Girona, A Coruña, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Burgos, Málaga
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Jerez de la Frontera, A Coruña, Pozuelo de Alarcón, Málaga, Valencia, Barcelona, Madrid, Santa Cruz de Tenerife
2023-12-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
L'Hospitalet Del Llobregat, Barcelona, Pozuelo de Alarcón, Majadahonda, San Cristóbal de La Laguna, Salamanca
2023-12-13
Active, closed
Sanofi
Phase 3
1,655
Murcia, Barcelona, Barakaldo, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Pontevedra, Seville, Córdoba
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Santiago de Compostela, Málaga, Seville, Palma, Barakaldo, Santander, A Coruña, Pozuelo de Alarcón
2023-12-12
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Badalona, Jerez de la Frontera, Pozuelo de Alarcón, EL Palmar (EL Palmar), Vigo, Barcelona, Huelva, Jaén
2023-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
L'Hospitalet de Llobregat, Pozuelo de Alarcón, Majadahonda, Málaga, Barcelona, Seville
2023-12-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo
2023-11-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Barcelona, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Madrid, Málaga
2023-11-12
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Santiago de Compostela, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Seville, Valencia
2023-09-18
Active, closed
Boehringer Ingelheim
Phase 2
268
Barcelona, L'Hospitalet de Llobregat, Mérida, Pozuelo de Alarcón
2023-09-08
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
NCT05875168Advanced Solid Tumor, Metastatic Solid Tumor
Daiichi Sankyo
Phase 1/2
590
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2023-08-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
735
L'Hospitalet Del Llobregat, Pozuelo de Alarcón, Valencia
2023-08-08
Active, closed
AC Immune SA
Phase 2
150
Barcelona, Donostia / San Sebastian, Madrid, Majadahonda, Pozuelo de Alarcón
2023-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Barcelona, Pozuelo de Alarcón, Madrid, Málaga, Valencia
2023-07-19
Active, closed
Hoffmann-La Roche
Phase 2
83
Pozuelo de Alarcón, El Palmar
2023-07-18
Active, closed
Klus Pharma Inc.
Phase 2
356
Majadahonda, Pozuelo de Alarcón, Barcelona, Málaga, Seville, Valencia
2023-04-19
Recruiting
Eli Lilly and Company
Phase 1/2
880
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Seville
2023-04-17
Recruiting
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
NCT05781217Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence, Androgen Deprivation Therapy
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Phase 3
534
L'Hospitalet de Llobregat, Fuenlabrada, Pozuelo de Alarcón, Barakaldo, Barcelona, Madrid, Tarragona, Valencia
2023-03-14
By invitation
Eli Lilly and Company
Phase 3
333
Esplugues de Llobregat, Las, Madrid, Pozuelo de Alarcón, Pamplona, Pontevedra, Manises
2023-03-09
Recruiting
Totus Medicines
Phase 1
241
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Valencia
2023-02-15
Active, closed
Stemline Therapeutics, Inc.
Phase 1/2
435
A Coruña, Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Valencia
2023-01-24
Active, closed
Janssen Research & Development, LLC
Phase 3
213
Alcorcón, Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Pamplona, Pozuelo de Alarcón
2022-12-15
Recruiting
PETHEMA Foundation
Phase 3
480
Alcalá de Henares, Pozuelo de Alarcón, Pamplona, Albacete, Badalona, Barcelona, Bilbao, Burgos
2022-11-10
Recruiting
Janssen Research & Development, LLC
Phase 3
1,590
Badalona, Barcelona, Granada, Jerez de la Frontera, Madrid, Palma de Mallorca, Pozuelo de Alarcón, Salamanca
2022-10-25
Active, closed
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
NCT05462717Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor
DrugElironrasib
Revolution Medicines, Inc.
Phase 1
222
Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Seville, Zaragoza
2022-09-19
By invitation
The Effect of Dual Attention in an EMDR Intervention
NCT05600868Trauma, Psychological, Traumatic Stress Disorder
Universidad Complutense de Madrid
Not applicable
100
Pozuelo de Alarcón
2022-09-01
Recruiting
Regeneron Pharmaceuticals
Phase 1
317
Santiago de Compostela, Badalona, Santander, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Salamanca
2022-08-17
Active, closed
AstraZeneca
Phase 2
194
Barcelona, Madrid, Málaga, Pamplona, Pozuelo de Alarcón
2022-08-11
Recruiting
AstraZeneca
Phase 1/2
695
A Coruña, Barcelona, Málaga, Pozuelo de Alarcón, Sant Cugat del Vallès, Seville
2022-06-24
By invitation
Universidad Complutense de Madrid
Not applicable
100
Pozuelo de Alarcón
2022-05-27
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
312
Barcelona, Leganés, Madrid, Moncloa-Aravaca, Pozuelo de Alarcón, Usera, Pamplona, Valencia
2022-05-25
Recruiting
Eli Lilly and Company
Phase 1
260
Barcelona, Madrid, Pozuelo de Alarcón, Valencia
2022-05-11
Recruiting
Vir Biotechnology, Inc.
Phase 1/2
645
Madrid, Barcelona, Pamplona, Pozuelo de Alarcón
2022-04-13
Active, closed
Pfizer
Phase 3
854
Santiago de Compostela, Barcelona, L'Hospitalet Del Llobregat, Terrassa, Badalona, Salamanca, Pozuelo de Alarcón, Madrid
2022-03-25
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Badajoz, Pozuelo de Alarcón, Oviedo, A Coruña, Barcelona, Madrid, Málaga, Zaragoza
2021-12-17
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Santiago Compostela, Vitoria-Gasteiz, L'Hospitalet de Llobregat, Albacete, Barcelona, Logroño, Pozuelo de Alarcón, Torrejón de Ardoz
2021-12-13
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Barcelona, Gijón, Las Palmas de Gran Canaria, Madrid, Palma, Pamplona, Pozuelo de Alarcón, Salamanca
2021-10-14
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Barcelona, Madrid, Majadahonda, Marbella, Oviedo, Pozuelo de Alarcón, Seville, Toledo
2021-09-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Barcelona, Pozuelo de Alarcón, Madrid, Valencia
2021-06-18
Active, closed
Hoffmann-La Roche
Phase 2
586
Elche, Sant Cugat del Vallès, Donosti-San Sebastián, A Coruña, Alcorcón, Móstoles, Pozuelo de Alarcón, Pamplona
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
746
L'Hospitalet de Llobregat, Pozuelo de Alarcón, EL Palmar (EL Palmar), Vigo, Barcelona, Madrid, Málaga, Seville
2021-03-17
Active, closed
Loxo Oncology, Inc.
Phase 3
238
L'Hospitalet de Llobregat, Toledo, Santiago de Compostela, Pozuelo de Alarcón, Madrid, Albacete, Barcelona, Cáceres
2021-03-09
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Badalona, Barcelona, Madrid, Murcia, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2021-02-01
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
DrugsIrinotecan·Gemcitabine
Artios Pharma Ltd
Phase 1/2
542
Elche, Sabadell, Santander, Barcelona, Lleida, Madrid, Pozuelo de Alarcón, El Palmar
2021-01-27
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Sant Cugat del Vallès, Pozuelo de Alarcón, Barcelona, Madrid, Valencia
2020-12-21
Active, closed
Hoffmann-La Roche
Phase 3
769
Pozuelo de Alarcón, Barcelona, Madrid, Murcia
2020-12-03
Active, closed
Hoffmann-La Roche
Phase 3
864
A Coruña, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Málaga
2020-11-26
Active, closed
AstraZeneca
Phase 1/2
702
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2020-11-12
Active, closed
Hoffmann-La Roche
Phase 3
985
A Coruña, Lleida, Pozuelo de Alarcón, Vigo, Barcelona, Cadiz, Madrid, Málaga
2020-10-26
Active, closed
Hoffmann-La Roche
Phase 3
992
L'Hospitalet de Llobregat, Donostia / San Sebastian, Pozuelo de Alarcón, A Coruña, Barcelona, Madrid, Seville, Valencia
2020-10-09
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Badalona, Barcelona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca, Santander
2020-09-17
Active, closed
AbbVie
Phase 3
531
Badalona, Córdoba, Pozuelo de Alarcón, Barcelona, Madrid, Salamanca, Seville, Valencia
2020-09-10
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
L'Hospitalet de Llobregat, Cáceres, Pozuelo de Alarcón, Marbella, Pamplona, Barcelona, Madrid, Pozuelo de Alarcon (madrid)
2020-08-20
Active, closed
Incyte Corporation
Phase 2
112
Alicante, Badalona, Barcelona, Boadilla del Monte, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón, Salamanca
2020-08-03
Active, closed
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
NCT04561362Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms
DrugsZelenectide pevedotin·Keytruda·Pembrolizumab
BicycleTx Limited
Phase 1/2
329
Barcelona, Madrid, Pozuelo de Alarcón, Santander
2020-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Majadahonda, Pozuelo de Alarcón, Málaga, Barcelona, Seville, Valencia
2020-07-06
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Palma, Barcelona, Pozuelo de Alarcón, Madrid, Salamanca, Valencia
2019-11-13
Active, closed
PETHEMA Foundation
Phase 3
302
Santiago de Compostela, Vitoria-Gasteiz, Badalona, Hospitalet Del Llobregat, San Sebastián, Jaén, Las Palmas de Gran Canaria, Pozuelo de Alarcón
2019-09-24
Active, closed
Sanofi
Observational
1,860
Barcelona, Pozuelo de Alarcón, Mieres, Madrid
2019-08-15
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Pozuelo de Alarcón, El Palmar, Vigo, Barcelona, Madrid, Salamanca, Seville, Valencia
2019-08-12
Active, closed
OncoVerity, Inc.
Phase 2
103
Pozuelo de Alarcón, Barcelona, Córdoba, Madrid, Palma, Salamanca, Valencia
2019-07-29
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Badalona, Barcelona, Cáceres, Girona, Pozuelo de Alarcón, Valencia, Madrid, Seville
2019-07-24
Recruiting
Aptose Biosciences Inc.
Phase 1/2
240
Barcelona, Pozuelo de Alarcón, Oviedo, Valencia
2019-03-11
Active, closed
Janssen Research & Development, LLC
Phase 3
765
A Coruña, Barcelona, Jerez de la Frontera, Madrid, Málaga, Pozuelo de Alarcón, Sabadell, Santander
2019-01-25
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Cadiz, L'Hospitalet de Llobregat, Barcelona, Donostia / San Sebastian, Salt, Majadahonda, Pozuelo de Alarcón, El Palmar
2018-12-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
L'Hospitalet de Llobregat, A Coruña, Pozuelo de Alarcón, Madrid, Valencia, Barcelona, Jaén, Seville
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Lugo, Pozuelo de Alarcón, Pamplona, Barcelona, Madrid, Valencia
2018-12-24
Active, closed
Merck Sharp & Dohme LLC
Phase 2
329
Pozuelo de Alarcón, Barcelona
2018-12-12
Active, closed
Genentech, Inc.
Phase 1
123
Pozuelo de Alarcón, Barcelona, Madrid, Valencia
2018-06-06
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
L'Hospitalet de Llobregat, Castellon, Pozuelo de Alarcón, Barcelona, Madrid, Málaga, Valencia
2018-04-17
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Barcelona, Madrid, Málaga, Ourense, Pontevedra, Pozuelo de Alarcón, Sabadell, Santander
2018-04-05
Active, closed
Janssen Research & Development, LLC
Phase 1
279
Badalona, Madrid, Pamplona, Pozuelo de Alarcón, Salamanca
2017-12-16
Active, closed
Eli Lilly and Company
Phase 3
5,637
Córdoba, Barcelona, Santiago de Compostela, Lleida, Pozuelo de Alarcón, Alcorcón, Madrid, Málaga
2017-07-12
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Active, closed
Eli Lilly and Company
Phase 3
545
Barcelona, Hospitalet, Palma, Pozuelo de Alarcón, Madrid, Pamplona, Seville, Valencia
2015-05-06
Rows per page Showing 1–148 of 148
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/pozuelo-de-alarc-n

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 148 of those studies with a site in Pozuelo de Alarcón.

How many clinical trials are recruiting in Pozuelo de Alarcón?

69 of the 148 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 76 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pozuelo de Alarcón), 148 studies
PhaseStudiesRecruitingShare
Phase 3773152%
Phase 1/2251816.9%
Phase 223715.5%
Phase 1161010.8%
Not applicable523.4%
Observational100.7%
Phase 4110.7%

Most active sponsors

Lead sponsors with the most studies (Pozuelo de Alarcón)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC209
Hoffmann-La Roche164
Janssen Research & Development, LLC125
AstraZeneca95
Eli Lilly and Company84
Regeneron Pharmaceuticals84
Novartis Pharmaceuticals74
Pfizer54
Amgen30
BioNTech SE33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.